Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Laboratory Study To Evaluate A Blood Biomarker That Can Distinguish Between the Presence Or Absence of Aggressive Prostate Cancer

NCT03256630 is registered in ClinicalTrials.gov with Genomic Health®, Inc. as lead sponsor.

NCT NCT03256630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03256630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Laboratory Study To Evaluate A Blood Biomarker That Can Distinguish Between the Presence Or Absence of Aggressive Prostate Cancer
Lead sponsor
Genomic Health®, Inc.
Phase
Observational
Overall status
Terminated
Start date
January 10, 2018
Completion date
February 28, 2019
Enrollment
128 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer